Schering Loses Bid To Split Suit Over Generic Vytorin
A federal judge has rejected Schering Corp.'s request to bifurcate its patent suit against Mylan Pharmaceuticals Inc. over a generic version of cholesterol drug Vytorin so that the plaintiff's infringement claims...To view the full article, register now.
Already a subscriber? Click here to view full article